Oncology Episode Payment Model in Hawaii
1 other identifier
interventional
7
1 country
1
Brief Summary
The HMSA Cancer Episode Payment Model (CEM) is a payment model designed to test the effects of better care coordination on health outcomes and costs of care for Hawaii Medical Services Association (HMSA) members with cancer who receive chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Aug 2018
Longer than P75 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2018
CompletedFirst Posted
Study publicly available on registry
May 14, 2018
CompletedStudy Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2028
February 20, 2026
February 1, 2026
8.4 years
April 19, 2018
February 18, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Composite quality score
Quality metrics included in the oncology model will be compared across the two arms.
1 year
Episode cost
Total spending of oncology patients in the episode will be compared across the two arms.
6 months
Utilization of acute and specialty care
Total utilization of acute and specialty care of oncology patients in the episode will be compared across the two arms
6 months
Secondary Outcomes (2)
Quality of care at end of life
6 months
Survival
one year
Study Arms (2)
Cancer Episode Payment Model
EXPERIMENTALOncologists in this arm will be paid for each member's episode of care. The episode of care is 6 months in duration. Oncologists will have the opportunity to receive performance-based payments based upon a set of 6 quality metrics.
Fee for Service
NO INTERVENTIONOncologists in this arm will not receive the intervention and will continue to be paid through fee-for-service.
Interventions
Oncologists will be paid for an episode of care with the opportunity to receive a value based payment based on 6 quality metrics.
Eligibility Criteria
You may qualify if:
- Any oncologist who practices with Hawaii Oncology and is a participating provider.
You may not qualify if:
- Any provider who does not practice with Hawaii Oncology.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- Hawaii Medical Service Associationcollaborator
Study Sites (1)
Hawaii Oncology
Honolulu, Hawaii, 96701, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 19, 2018
First Posted
May 14, 2018
Study Start
August 1, 2018
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 31, 2028
Last Updated
February 20, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share